Orexo AB (ORXOF) Announces A New MSEK 200 Credit Facility  
12/12/2013 9:14:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:

Orexo AB, “Orexo” (OTCQX: ORXOY; NASDAQ OMX Stockholm: ORX) announces closing of a MSEK 200 (MUSD 30) revolving credit facility with Danske Bank. MSEK 100 will be available immediately upon closing and the remaining MSEK 100 when specific Zubsolv® revenue milestones are met. The facility has a two year tenure with an extension option and the facility replaces the existing overdraft facility of MSEK 50.

Help employers find you! Check out all the jobs and post your resume.